检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵霞 ZHAO Xia(Department of Obstetrics and Gynecology,big bridge hospital of Zhengzhou,zhengzhou,453003,China)
出 处:《新疆医学》2022年第9期1068-1070,共3页Xinjiang Medical Journal
摘 要:目的分析芬吗通片对月经失调患者的总有效率。方法入组研究对象是2018年5月-2020年5月本院116例月经失调患者,分组依照随机法(每组n=58),参照组采纳克龄蒙片治疗,病例组采纳芬吗通片治疗,对比两组临床疗效、卵巢激素水平、不良反应发生率、SF-36评分。结果病例组临床总有效率(96.55%)高于参照组(74.14%),病例组治疗后血清E以及P均高于参照组,差异均具有统计学意义(P<0.05)。病例组不良反应发生率(3.45%)低于参照组(15.52%),病例组治疗后SF-36评分高于参照组,差异均具有统计学意义(P<0.05)。结论芬吗通片可有效调节月经失调患者月经周期、卵巢激素水平,提高生活质量,且不良反应较少,值得借鉴。Objective To analyze the total effective rate of fenmatong tablets in patients with menstrual disorders.Methods 116 patients with menstrual disorders in our hospital from May 2018 to may 2020 were enrolled in the study.They were randomly divided into two groups(n=58 in each group).The control group was treated with kelingmeng tablets and the experimental group was treated with fenmatong tablets.The clinical efficacy,ovarian hormone level,incidence of adverse reactions and SF-36 score between the two groups were compared.Results The clinical total effective rate of the experimental group(96.55%)was higher than that of the control group(74.14%),the serum Eand P of the experimental group after treatment were higher than those of the control group,the differences were statistically significant(P<0.05).The incidence of adverse reactions in the experimental group(3.45%)was lower than that in the control group(15.52%).The SF-36 score in the expeirmental group was higher than that in the control group after treatment,and the differences were statistically significant(P<0.05).Conclusion Fenmatong tablets can effectively regulate the menstrual cycle and ovarian hormone levels of patients with menstrual disorders,improve the lifequality,and has less adverse reactions,which is worthy of reference.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222